Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 2Gastrointestinal 2Tumor-Agnostic 1Thoracic 1Plasma cell 1Myeloid 1Head & Neck 1Gynecologic 1Dermatologic 1Breast 1

Conditions

Uterine Cervical Neoplasms 1Behavior 1

Interventions

Paclitaxel 575Carboplatin 521Cisplatin 351Bevacizumab 252pembrolizumab 228Gemcitabine 157Topotecan 128Cyclophosphamide 128liposomal doxorubicin 127olaparib 120Taxes 113Radiotherapy 110Docetaxel 94Brachytherapy 89Doxorubicin 84Drug Therapy 81niraparib 75Nivolumab 71Magnetic Resonance Spectroscopy 71Specimen Handling 65fludarabine 57Biopsy 55Hyperthermic Intraperitoneal Chemotherapy 53Filgrastim 52Letrozole 50Oxaliplatin 48durvalumab 47Immunoglobulin G 47atezolizumab 46Platinum 44

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × House Calls × Gynecologic × Clear all
NCT03076879 2019-09-18

Increasing Participation in Cervical Cancer Screening and Risk for Beliefs/Attitudes Among Women at Risk

Selcuk University

Phase NA Completed
114 enrolled
Gynecologic

Behavior, Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡